Therefore, dysregulated anterograde endosome trafficking machinery may account for the increased secretion of VEGF in prostate cancer cells, in combination with factors such as myosin-mediated endosome tethering (Figure 4A). The gene discussed is VEGFA; the disease is prostate cancer.